Literature DB >> 30054618

Assessing the Precision of ICD-10 Codes for Uveitis in 2 Electronic Health Record Systems.

Alan G Palestine1, Pauline T Merrill2,3, Sophia M Saleem4, Douglas A Jabs4,5,6, Jennifer E Thorne6,7.   

Abstract

Importance: Electronic health record (EHR) systems based on International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) coding of disease entities are increasingly being used to generate large data sets for analysis. However, the reproducibility of ICD-10 coding in uveitis has not been assessed across EHR platforms, and imprecision in coding may lead to improper conclusions in big-data analyses. Objective: To compare ICD-10 coding of uveitis using 2 EHR systems. Design, Setting, and Participants: This study compares ICD-10 codes for 27 uveitic diseases generated by the Epic and MDIntelleSys EHR systems to the ICD-10 descriptions associated with the codes. No patient data were assessed in this study. Main Outcomes and Measures: The number of diseases for which ICD-10 coding differed between the 2 systems.
Results: Thirteen of 27 uveitic diseases were coded differently by the 2 EHR systems. Coding imprecision was notable in that the Epic system returned 16 ICD-10 codes and the MDIntelleSys returned 12 ICD-10 codes to describe 13 diseases; 4 diseases had multiple codes returned, and 6 codes were used to describe more than 1 disease. For example, MDIntelleSys uses ICD-10 code H30.13 for both birdshot choroiditis and acute retinal necrosis, while Epic uses H30.9 for both birdshot choroiditis and multiple evanescent white dot syndrome; MDIntelleSys uses this code for multifocal choroiditis. Furthermore, the ICD-10 descriptions for certain codes lack specificity, allowing variable interpretation by the coder. Conclusions and Relevance: This study suggests there is substantial disparity in the ICD-10 codes that are generated for specific uveitides by the 2 EHR systems studied. This result implies that analysis of large databases generated from the pooling of EHR data could produce results with substantial bias because of misclassification resulting from conflicting and imprecise coding of uveitides. Therefore, research into outcomes, costs, health care utilization, and epidemiology in uveitis might be improved if a more uniform coding system to describe ocular inflammatory disease is implemented.

Entities:  

Mesh:

Year:  2018        PMID: 30054618      PMCID: PMC6583860          DOI: 10.1001/jamaophthalmol.2018.3001

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  6 in total

1.  Interobserver Agreement Among Uveitis Experts on Uveitic Diagnoses: The Standardization of Uveitis Nomenclature Experience.

Authors:  Douglas A Jabs; Andrew Dick; John T Doucette; Amod Gupta; Susan Lightman; Peter McCluskey; Annabelle A Okada; Alan G Palestine; James T Rosenbaum; Sophia M Saleem; Jennifer Thorne; Brett Trusko
Journal:  Am J Ophthalmol       Date:  2017-11-06       Impact factor: 5.258

2.  Big Data and Uveitis.

Authors:  Cecilia S Lee; Aaron Y Lee; Gary N Holland; Russell N Van Gelder; Adnan Tufail
Journal:  Ophthalmology       Date:  2016-11       Impact factor: 12.079

Review 3.  The IRIS® Registry : Purpose and perspectives.

Authors:  D W Parke Ii; F Lum; W L Rich
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

4.  Approach to the diagnosis of the uveitides.

Authors:  Douglas A Jabs; Jacqueline Busingye
Journal:  Am J Ophthalmol       Date:  2013-05-10       Impact factor: 5.258

Review 5.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

6.  The Standardization of Uveitis Nomenclature (SUN) Project. Development of a clinical evidence base utilizing informatics tools and techniques.

Authors:  B Trusko; J Thorne; D Jabs; R Belfort; A Dick; S Gangaputra; R Nussenblatt; A Okada; J Rosenbaum
Journal:  Methods Inf Med       Date:  2013-02-08       Impact factor: 2.176

  6 in total
  7 in total

1.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

2.  Techniques for improving ophthalmic studies performed on administrative databases.

Authors:  Durga S Borkar; Lucia Sobrin; Rebecca A Hubbard; John H Kempen; Brian L VanderBeek
Journal:  Ophthalmic Epidemiol       Date:  2018-12-06       Impact factor: 1.648

3.  Epidemiology of Uveitis in Olmsted County, Minnesota: A Population-Based Follow-Up Study.

Authors:  Timothy T Xu; Margaret M Reynolds; David O Hodge; Wendy M Smith
Journal:  Ocul Immunol Inflamm       Date:  2021-11-22       Impact factor: 3.728

4.  Accuracy of the International Classification of Diseases, 9th Revision for Identifying Infantile Eye Disease.

Authors:  Timothy T Xu; Cole E Bothun; Tina M Hendricks; Sasha A Mansukhani; Erick D Bothun; Launia J White; Brian G Mohney
Journal:  Ophthalmic Epidemiol       Date:  2021-11-25

5.  Decreased risk of non-infectious anterior uveitis with statin therapy in a large healthcare claims database.

Authors:  Lucia Sobrin; Yinxi Yu; Samuel Han; Gayatri Susarla; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-29       Impact factor: 3.535

6.  Which Electronic Health Record System Should We Use? A Systematic Review.

Authors:  Mohammed Al Ani; George Garas; James Hollingshead; Drostan Cheetham; Thanos Athanasiou; Vanash Patel
Journal:  Med Princ Pract       Date:  2022-05-18       Impact factor: 2.132

7.  Exploring the association between precipitation and population cases of ocular toxoplasmosis in Colombia.

Authors:  Laura Boada-Robayo; Danna Lesley Cruz-Reyes; Carlos Cifuentes-González; William Rojas-Carabali; Ángela Paola Vargas-Largo; Alejandra de-la-Torre
Journal:  PLoS Negl Trop Dis       Date:  2022-10-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.